Rlje Films has acquired the North America, U.K., Ireland, Australia and New Zealand rights to “Sympathy for the Devil,” an upcoming psychological thriller starring Nicolas Cage (“Mandy”) and Joel Kinnaman (“The Suicide Squad” film series).
An agreement was reached between Rlje Films chief acquisitions officer Mark Ward and Christian Mercuri’s Capstone Global, an international company in charge of the feature’s global sales.
“This is our eighth collaboration with Nicolas Cage, which includes ‘Mandy’ — a critically-acclaimed film that has a huge cult following,” Ward said. “Once again, he doesn’t disappoint. In this film, Cage and Joel Kinnaman bring to life a suspenseful tale on screen that will keep audiences guessing.”
“Sympathy for the Devil” features Kinnaman as a nameless driver who is forced to taxi a mysterious passenger (Cage) at gunpoint. Other actors confirmed to appear in the film are Kaiwi Lyman, Cameron Lee Price, Burns Burns,...
An agreement was reached between Rlje Films chief acquisitions officer Mark Ward and Christian Mercuri’s Capstone Global, an international company in charge of the feature’s global sales.
“This is our eighth collaboration with Nicolas Cage, which includes ‘Mandy’ — a critically-acclaimed film that has a huge cult following,” Ward said. “Once again, he doesn’t disappoint. In this film, Cage and Joel Kinnaman bring to life a suspenseful tale on screen that will keep audiences guessing.”
“Sympathy for the Devil” features Kinnaman as a nameless driver who is forced to taxi a mysterious passenger (Cage) at gunpoint. Other actors confirmed to appear in the film are Kaiwi Lyman, Cameron Lee Price, Burns Burns,...
- 3/16/2023
- by Katie Reul
- Variety Film + TV
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.